Home / Brands / Golden State Medical Supply
Golden State Medical Supply Recalls
53 recalls on record · June 11, 2014 to June 17, 2026 · Drugs
Recalls by year
14
15
16
18
19
20
21
22
23
24
25
26
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
June 17, 2026DrugsFDA
Golden State Medical Supply Inc. recalls GSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured by Kremers Urban Ph
Hazard: Failed Dissolution Specifications: During 12-month long-term stability testing, subject lot was out of specification (low) for stage 3 dissolution at the 24-hour timepoint.
May 27, 2026DrugsFDA
Golden State Medical Supply Inc. recalls Primidone Tablets, USP, 250 mg, 100-count bottle, RX only, Manufactured by: Lannett Company, Inc., Marketed by: GSMS, In
Hazard: Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
May 27, 2026DrugsFDA
Golden State Medical Supply Inc. recalls Primidone Tablets, USP, 50 mg, 50-count bottle, RX only, Manufactured by: Lannett Company, Inc., Marketed by: GSMS, Inco
Hazard: Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
December 24, 2025DrugsFDA
Golden State Medical Supply Inc. recalls Baclofen Tablets USP, 10 mg, 1000-count bottles, Rx only, Marketed by: GSMS, Incorporated, CA 93012 USA. NDC 51407-973-1
Hazard: Presence of Foreign Tablets/Capsules
November 26, 2025DrugsFDA
Golden State Medical Supply Inc. recalls NIACIN Extended-Release Tablets, USP, 1,000 mg, 90 tablets per bottle, Rx only, Manufactured by: Kremers Urban Pharmaceu
Hazard: Failed Dissolution Specifications
March 26, 2025DrugsFDA
Golden State Medical Supply Inc. recalls PRASUGREL TABLETS, 5 mg, 30 tablet bottles, Rx only, packaged by GSMS, Incorporated, Camarillo, CA 93012 NDC 51407-444-3
Hazard: Failed Dissolution Specifications
July 3, 2024DrugsFDA
Golden State Medical Supply Inc. recalls Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, a) 30 capsules bottles, NDC 60429-165-30; b) 90 capsules bottle
Hazard: CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the proposed interim limit.
March 6, 2024DrugsFDA
Golden State Medical Supply Inc. recalls Fluticasone Propionate Nasal Spray USP, 50 mcg per spray, 120 metered sprays, 16 g net fill, Rx only, Manufactured by: A
Hazard: CGMP Deviations:Suspected potential presence of Burkholderia cepacia complex
February 7, 2024DrugsFDA
Golden State Medical Supply Inc. recalls Budesonide Extended-Release Tablets, 9 mg, 30-count bottles, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA, UP
Hazard: Failed Dissolution Specifications
December 6, 2023DrugsFDA
Golden State Medical Supply Inc. recalls PAROXETINE tablets, USP, 40 mg, Packaged as a) 30-count bottle, NDC 60429-737-30; b) 90-count bottle NDC 60429-737-90;
Hazard: Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine
December 6, 2023DrugsFDA
Golden State Medical Supply Inc. recalls PAROXETINE tablets, USP, 20 mg, Packaged as a) 90-count bottle NDC 60429-735-90; b)1000-count bottle, NDC 60429-735-10;
Hazard: Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine
December 6, 2023DrugsFDA
Golden State Medical Supply Inc. recalls PAROXETINE tablets, USP, 10 mg, Packaged as a) 30-count bottle, NDC 60429-734-30; b) 90-count bottle NDC 60429-734-90;
Hazard: Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine
June 14, 2023DrugsFDA
Golden State Medical Supply Inc. recalls Travoprost Ophthalmic Solution, USP (Ionic Buffered Solution), 0.004%, Rx only, Manufactured by Apotex Inc., Manufactur
Hazard: Lack of Assurance of Sterility: Tamper Evidence Seal is missing on secondary container.
November 2, 2022DrugsFDA
Golden State Medical Supply Inc. recalls Atenolol Tablets, USP, 25 mg, 1000-count bottle, Rx only, Manufactured by: ALPHAPHARM PTY LTD, Marketed by: GSMS, Incorp
Hazard: Label Mix - up; a bottle labeled as Atenolol 25mg Tablets contained Clopidogrel 75mg Tablets
October 26, 2022DrugsFDA
Golden State Medical Supply Inc. recalls Rifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Manufactured by Patheon Pharmaceuticals Inc., OH, Packaged by
Hazard: Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).
October 26, 2022DrugsFDA
Golden State Medical Supply Inc. recalls Rifampin Capsules, USP, 300 mg, packaged in a) 30-count bottle (NDC 51407-323-30), b) 60-count bottle (NDC 51407-323-60)
Hazard: Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).
July 13, 2022DrugsFDA
Golden State Medical Supply Inc. recalls Enalapril Maleate Tablets, USP; 20 mg; 90 tablets, NDC 60429-186-90; manufactured by Taro Pharmaceutical Industries, Ltd
Hazard: CGMP Deviations
July 13, 2022DrugsFDA
Golden State Medical Supply Inc. recalls Enalapril Maleate Tablets, USP; 10 mg; 90 tablets, NDC 60429-185-90; manufactured by Taro Pharmaceutical Industries, Ltd
Hazard: CGMP Deviations
July 13, 2022DrugsFDA
Golden State Medical Supply Inc. recalls Enalapril Maleate Tablets, USP; 5 mg; 90 tablets, NDC 60429-184-90; manufactured by Taro Pharmaceutical Industries, Ltd.
Hazard: CGMP Deviations
July 13, 2022DrugsFDA
Golden State Medical Supply Inc. recalls Enalapril Maleate Tablets, USP; 2.5 mg; 90 tablets, NDC 60429-183-90; manufactured by Taro Pharmaceutical Industries, Lt
Hazard: CGMP Deviations
March 23, 2022DrugsFDA
Golden State Medical Supply Inc. recalls Alprazolam Tablets, USP 1mg, 180-count bottles, Rx only, Manufactured by ULTRAlab Laboratories, Inc., NY; Packaged by GS
Hazard: CGMP Deviation: Potential cross-contamination with other drug substance during the manufacturing process.
November 17, 2021DrugsFDA
Golden State Medical Supply Inc. recalls Ezetimibe and Simvastatin Tablets, 10 mg/80mg, 500 tablet bottles, Rx only, Manufactured by Dr. Reddy's Laboratories LA
Hazard: Failed Excipient Specification; product manufactured using an excipient found to be OOS for conductivity
November 17, 2021DrugsFDA
Golden State Medical Supply Inc. recalls Ezetimibe and Simvastatin Tablets, 10 mg/40mg, a) 90 Tablets, b) 500 tablets, Rx only, Manufactured by Dr. Reddy's Labor
Hazard: Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle
March 31, 2021DrugsFDA
Golden State Medical Supply Inc. recalls Omeprazole Delayed Release Capsules, USP, 20 mg, 1000-count bottles, Rx only, Packaged by GSMS Incorporated, Camarillo,
Hazard: Failed Impurities/Degradation Specifications: Out of Specification results obtained for unknown impurities during stability testing by manufacturer
December 9, 2020DrugsFDA
Golden State Medical Supply Inc. recalls ARIPIPRAZOLE TABLETS, 15 mg, 30-count. bottles, Rx Only, GSMS Incorporated, Manufactured by: Apotex Inc. Toronto, Ontari
Hazard: FAILED DISSOLUTION SPECIFICATIONS: Possibility of out-of-specification (OOS) dissolution limits for the remaining shelf life of the Aripiprazole Tablets
August 19, 2020DrugsFDA
Golden State Medical Supply Inc. recalls Clobetasol Propionate Cream, USP, 0.05%, packaged in a)15g Tubes (NDC 60429-902-15) and b) 45g Tubes (NDC 60429-902-45),
Hazard: Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity.
April 22, 2020DrugsFDA
Golden State Medical Supply Inc. recalls Losartan Potassium Tablets, USP, 25 mg, Rx only, a) 30 ct. (NDC 60429-316-30) b) 90ct. (NDC 60429-316-90) c) 1,000 ct. (
Hazard: CGMP Deviations: Impurity for N-nitroso-N-methyl-4-aminobutryric Acid (NBMA) detected in active ingredient (API) used to manufacture finished products.
March 4, 2020DrugsFDA
Golden State Medical Supply Inc. recalls TRAMADOL HYDROCHLORIDE Tablets, USP, 50 mg, Rx Only a)100-count bottles (NDC 60429-588-01) b) 500-count bottle (NDC 6042
Hazard: Labeling: Incorrect package insert - Patient leaflets for the specified lots of unscored tablets contain language relative to a 25 mg dosing titration that necessitates the use of a scored 50 mg tablet.
November 20, 2019DrugsFDA
Golden State Medical Supply Inc. recalls GSMS: Ranitidine Capsules 300 mg, Rx only, 100 count bottles (NDC 51407-098-01) Manufactured by Novitium Pharma LLC, 70
Hazard: CGMP Deviations: Presence of NDMA impurity detected in product.
November 20, 2019DrugsFDA
Golden State Medical Supply Inc. recalls GSMS: Ranitidine Capsules 150 mg, Rx only, 500 count bottles (NDC 51407-097-05) Manufactured by Novitium Pharma LLC, 70
Hazard: CGMP Deviations: Presence of NDMA impurity detected in product.